1. Home
  2. IRWD vs ATRO Comparison

IRWD vs ATRO Comparison

Compare IRWD & ATRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRWD
  • ATRO
  • Stock Information
  • Founded
  • IRWD 1998
  • ATRO 1968
  • Country
  • IRWD United States
  • ATRO United States
  • Employees
  • IRWD N/A
  • ATRO N/A
  • Industry
  • IRWD Biotechnology: Pharmaceutical Preparations
  • ATRO Military/Government/Technical
  • Sector
  • IRWD Health Care
  • ATRO Industrials
  • Exchange
  • IRWD Nasdaq
  • ATRO Nasdaq
  • Market Cap
  • IRWD 716.9M
  • ATRO 634.4M
  • IPO Year
  • IRWD 2010
  • ATRO N/A
  • Fundamental
  • Price
  • IRWD $4.21
  • ATRO $16.54
  • Analyst Decision
  • IRWD Buy
  • ATRO Hold
  • Analyst Count
  • IRWD 4
  • ATRO 1
  • Target Price
  • IRWD $12.00
  • ATRO $20.00
  • AVG Volume (30 Days)
  • IRWD 1.4M
  • ATRO 203.0K
  • Earning Date
  • IRWD 11-07-2024
  • ATRO 11-06-2024
  • Dividend Yield
  • IRWD N/A
  • ATRO N/A
  • EPS Growth
  • IRWD N/A
  • ATRO N/A
  • EPS
  • IRWD N/A
  • ATRO N/A
  • Revenue
  • IRWD $378,418,000.00
  • ATRO $782,178,000.00
  • Revenue This Year
  • IRWD N/A
  • ATRO $15.70
  • Revenue Next Year
  • IRWD N/A
  • ATRO $6.98
  • P/E Ratio
  • IRWD N/A
  • ATRO N/A
  • Revenue Growth
  • IRWD N/A
  • ATRO 19.95
  • 52 Week Low
  • IRWD $3.79
  • ATRO $14.58
  • 52 Week High
  • IRWD $15.70
  • ATRO $23.74
  • Technical
  • Relative Strength Index (RSI)
  • IRWD 46.85
  • ATRO 37.70
  • Support Level
  • IRWD $4.26
  • ATRO $17.87
  • Resistance Level
  • IRWD $5.07
  • ATRO $17.24
  • Average True Range (ATR)
  • IRWD 0.32
  • ATRO 0.85
  • MACD
  • IRWD -0.02
  • ATRO -0.18
  • Stochastic Oscillator
  • IRWD 24.56
  • ATRO 13.61

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

About ATRO Astronics Corporation

Astronics Corp supplies products to the aerospace, defense, and electronics industries. The company has two reportable segments namely Aerospace and Test Systems. The aerospace segment serves three primary markets: military, commercial transport, and General Aviation. The Test Systems segment serves the aerospace, defense, and semiconductor markets. The company generates a majority of its revenue from the Aerospace segment. Geographically, it generates a majority of its revenue from the United States.

Share on Social Networks: